Clinical Trial Update: Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients [NA]

View source ↗

Summary

Clinical trial evaluating different doses of rosuvastatin for regression of critical coronary atherosclerosis in patients with acute coronary syndrome; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Acute Coronary Syndrome | NA | Status: UNKNOWN